CFD
SAGE icon

Creative Financial Designs’s Sage Therapeutics SAGE Stock Holding History

Creative Financial Designs’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-124
Closed -$5K – 1406
2021
Q3 		$5K Hold
124
– – ﹤0.01% 1168
2021
Q2 		$7K Hold
124
– – ﹤0.01% 1096
2021
Q1 		$9K Hold
124
– – ﹤0.01% 958
2020
Q4 		$11K Hold
124
– – ﹤0.01% 853
2020
Q3 		$8K Hold
124
– – ﹤0.01% 852
2020
Q2 		$5K Buy
+124
New +$4.5K ﹤0.01% 879

Other funds holding SAGE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Creative Financial Designs's SAGE Position: Q4 2021 in Review

Creative Financial Designs sold out of Sage Therapeutics (SAGE) in Q4 2021, closing a stake of 124 shares — an estimated $5K sold.

Creative Financial Designs first reported a position in SAGE in Q2 2020 and held it in 6 quarters. The position peaked at $11K in Q4 2020. 217 funds tracked by Wall St. Rank hold SAGE as of Q4 2021.

  • Creative Financial Designs reported no remaining Sage Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Creative Financial Designs sold 124 Sage Therapeutics shares in Q4 2021, an estimated $5K.
  • Creative Financial Designs first reported a position in Sage Therapeutics in Q2 2020 and held it in 6 quarters.
  • Creative Financial Designs's Sage Therapeutics position peaked at $11K in Q4 2020.
  • 217 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2021.

Based on Creative Financial Designs's 13F filing for Q4 2021, filed 26 Jan 2022.